8 Biggest Mid-Day Gainers For Monday

shares jumped 470.53 percent to $10.84.

shares surged 90.90 percent to $2.31.

shares climbed 46.93 percent to $192.60 after

announced plans to acquire LinkedIn for $196 per share.

shares jumped 44.65 percent to $2.70 as the company reported that that it has submitted an Investigational New Drug application to the FDA to initiate a Phase 1 clinical trial of EBI-031 for ocular diseases. The company announced the signing of exclusive license agreement with Roche covering IL-6 antagonist antibody.

shares surged 9.82 percent to $0.681 after the company reported an agreement with the FDA on confirmatory Phase 3 study protocol for Firdapse in Lambert-Eaton myasthenic syndrome.

shares gained 9.74 percent to $62.97 following Orlando shootings on Sunday.

gained 7.43 percent to $23.00 following Orlando shootings on Sunday. Gun stocks, including Smith & Wesson, were trading higher as the shooting could result in a surge of gun sales to individuals looking to protect themselves.

shares rose 4.52 percent to $59.91. SAIC reported better-than-expected results for its first quarter.